Cognitive Process-based Real-time fMRI Neurofeedback in MDD and Rumination
Completed · Not applicable · Has a placebo group
Conditions studied: Depression, Anxiety
In brief
The purpose of this study is to assess the feasibility and efficacy of real-time fMRI neurofeedback for rumination.
Key facts
- Study ID
- NCT04941066
- Run by
- Laureate Institute for Brain Research, Inc.
- People needed
- 44
- Starts
- 2021-03-01
- Expected to finish
- 2022-03-31
- Last updated by the study team
- 2023-01-18
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Good general health
- DSM-5 diagnosis of major depressive disorder (MDD)
You may not qualify if…
- General Exclusion Criteria:
- Pregnancy
- Medical Conditions:
- Moderate to severe traumatic brain injury (>30 min. loss of consciousness or >24 hours posttraumatic amnesia) or other neurocognitive disorder with evidence of neurological deficits.
- Presence of co-morbid medical conditions not limited to but including cardiovascular (e.g., history of acute coronary event, stroke) and neurological diseases (e.g., Parkinson's disease), as well as pain disorders.
- Presence of an uncontrolled medical condition that is deemed by the investigators to interfere with the proposed study procedures, or to put the study participant at undue risk.
- Psychiatric Disorders:
- Current severe suicidal ideation or attempt within the past 12 months.
- Psychosis
- Bipolar disorder
- Substance abuse or dependence within the previous 6 months
- Contraindications for MRI:
- Bodily implants of unsafe paramagnetic materials such as pace-makers and aneurysm clips.
- Claustrophobia that is severe enough to preclude MRI scanning.
- Medications:
- Evidence of recreational drug use from a urine test.
Where it is running
- Laureate Institute for Brain Research — Tulsa, Oklahoma, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.